Obstructive sleep apnoea and cardiovascular disease
- PMID: 24321805
- DOI: 10.1016/S2213-2600(12)70051-6
Obstructive sleep apnoea and cardiovascular disease
Abstract
Obstructive sleep apnoea (OSA) is a common health concern caused by repeated episodes of collapse of the upper airway during sleep. The events associated with OSA lead to brain arousal, intrathoracic pressure changes, and intermittent episodes of hypoxaemia and reoxygenation. These events activate pathways such as oxidative stress, sympathetic activation, inflammation, hypercoagulability, endothelial dysfunction, and metabolic dysregulation that predispose patients with OSA to hypertension and atherosclerosis. OSA is a common cause of systemic hypertension and should be suspected in hypertensive individuals, especially those with resistant hypertension. In patients with OSA, continuous positive airway pressure (CPAP) treatment reduces blood pressure, and its effects are related to compliance and baseline blood pressure. Evidence suggests that OSA is a risk factor for stroke and heart failure. An association between coronary heart disease and OSA seems to be limited to middle-aged men (30-70 years). Cardiac rhythm disorders occur in about half of patients with OSA, but their clinical relevance is still unknown. The association of OSA with cardiovascular risk is mainly based on studies in men, and an association has yet to be established in women. Data on older patients is similarly scarce. Currently, there is not enough evidence to support treatment with CPAP for primary or secondary prevention of cardiovascular disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Obstructive sleep apnea and cardiovascular disease.Mayo Clin Proc. 2004 Aug;79(8):1036-46. doi: 10.4065/79.8.1036. Mayo Clin Proc. 2004. PMID: 15301332 Review.
-
Hypertension in obstructive sleep apnea: risk and therapy.Expert Rev Cardiovasc Ther. 2009 Jun;7(6):619-26. doi: 10.1586/erc.09.25. Expert Rev Cardiovasc Ther. 2009. PMID: 19505277 Review.
-
[Obstructive sleep apnea-related cardiovascular disease].Med Klin (Munich). 2006 Apr 15;101(4):321-7. doi: 10.1007/s00063-006-1041-9. Med Klin (Munich). 2006. PMID: 16607489 Review. German.
-
[Sleep apnea syndromes and cardiovascular disease].Bull Acad Natl Med. 2005 Mar;189(3):445-59; discussion 460-4. Bull Acad Natl Med. 2005. PMID: 16149210 Review. French.
-
Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences.Nutr Metab Cardiovasc Dis. 2007 Mar;17(3):233-40. doi: 10.1016/j.numecd.2006.12.005. Epub 2007 Feb 20. Nutr Metab Cardiovasc Dis. 2007. PMID: 17314035 Review.
Cited by
-
Effect of CPAP Therapy on 24-Hour Intraocular Pressure-Related Pattern From Contact Lens Sensors in Obstructive Sleep Apnea Syndrome.Transl Vis Sci Technol. 2021 Apr 1;10(4):10. doi: 10.1167/tvst.10.4.10. Transl Vis Sci Technol. 2021. PMID: 34003989 Free PMC article.
-
Sleep Disorders in Stroke: An Update on Management.Aging Dis. 2021 Apr 1;12(2):570-585. doi: 10.14336/AD.2020.0707. eCollection 2021 Apr. Aging Dis. 2021. PMID: 33815883 Free PMC article. Review.
-
Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer.Cancers (Basel). 2023 Feb 7;15(4):1061. doi: 10.3390/cancers15041061. Cancers (Basel). 2023. PMID: 36831404 Free PMC article. Review.
-
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies.Eur Arch Otorhinolaryngol. 2019 Aug;276(8):2331-2338. doi: 10.1007/s00405-019-05486-6. Epub 2019 Jun 13. Eur Arch Otorhinolaryngol. 2019. PMID: 31197532
-
Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.Respir Res. 2022 Jun 21;23(1):163. doi: 10.1186/s12931-022-02092-9. Respir Res. 2022. PMID: 35729539 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources